financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Akebia Therapeutics Says EMA Panel Recommends Approval of Xoanacyl for Chronic Kidney Disease Treatment
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Akebia Therapeutics Says EMA Panel Recommends Approval of Xoanacyl for Chronic Kidney Disease Treatment
Apr 3, 2025 7:29 AM

10:01 AM EDT, 04/03/2025 (MT Newswires) -- Akebia Therapeutics ( AKBA ) said Thursday that the European Medicines Agency's Committee for Medicinal Products for Human Use recommended approval of Xoanacyl for treating elevated serum phosphorus and iron deficiency in adults with chronic kidney disease.

The company said Averoa, a biopharmaceutical company specializing in renal treatments, licensed the rights from Akebia to develop and market ferric citrate in the European Economic Area and certain countries in Europe and the Middle East.

The European Commission is expected to reach a final decision on Xoanacyl's approval within about two months, the biopharmaceutical company said.

Shares of Akebia were down more than 3% in recent Thursday trading.

Price: 1.87, Change: -0.06, Percent Change: -3.11

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Buckle's Same-Store, Overall Net Sales Fall in April
Buckle's Same-Store, Overall Net Sales Fall in April
May 9, 2024
11:15 AM EDT, 05/09/2024 (MT Newswires) -- Buckle (BKE) reported Thursday a 6% year-over-year fall in comparable store net sales at stores open at least one year during the four weeks ended May 4. Net sales for the fiscal month declined 8.1% to $79.9 million from $86.9 million a year ago, the company said. Price: 38.71, Change: +0.05, Percent Change:...
 --Penske Automotive Raises Quarterly Dividend by 10% to $0.96 per Share, Payable June 4 to Shareholders of Record May 20
--Penske Automotive Raises Quarterly Dividend by 10% to $0.96 per Share, Payable June 4 to Shareholders of Record May 20
May 9, 2024
11:15 AM EDT, 05/09/2024 (MT Newswires) -- Price: 154.60, Change: +1.73, Percent Change: +1.13 ...
 Chimera Investment's Q1 Non-GAAP Earnings, Net Interest Income Decline
Chimera Investment's Q1 Non-GAAP Earnings, Net Interest Income Decline
May 9, 2024
11:16 AM EDT, 05/09/2024 (MT Newswires) -- Chimera Investment ( CIM ) shares were up more than 10% in recent trading Thursday after the company reported its Q1 financial results. The company reported Q1 earnings available for distribution, a non-GAAP measure, of $0.12 per diluted share, down from $0.13 a year earlier. Four analysts polled by Capital IQ expected $0.16....
 Corby Spirit and Wine Reports Higher Q3 Adjusted Profit, as Operating Earnings Almost Double
Corby Spirit and Wine Reports Higher Q3 Adjusted Profit, as Operating Earnings Almost Double
May 9, 2024
11:19 AM EDT, 05/09/2024 (MT Newswires) -- Corby Spirit and Wine (CSW-A.TO) on Thursday reported higher third quarter adjusted earnings, as earnings from operations almost doubled. The company reported adjusted net earnings, excluding most one-time items, of $5.6 million, or $0.20 per share, up from $3.9 million, or $0.14, in the year-prior quarter. Revenue was not disclosed. Earnings from operations...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved